Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Aug;12(4):237–246. doi: 10.1080/09629350310001599684

Differential regulation of the release of tumor necrosis factor-alpha and of eicosanoids by mast cells in rat airways after antigen challenge.

Aryene Goes Trezena 1, Zilma Lucia da Silva 1, Ricardo Martins Oliveira-Filho 1, Amilcar Sabino Damazo 1, Anita Hilda Straus 1, Helio Kiyoshi Takahashi 1, Sonia Maria Oliani 1, Wothan Tavares de Lima 1
PMCID: PMC1781613  PMID: 14514475

Abstract

BACKGROUND: Rat trachea display a differential topographical distribution of connective tissue mast cells (CTMC) and mucosal mast cells (MMC) that may imply regional differences in the release of allergic mediators such as tumor necrosis factor-alpha (TNF-alpha) and eicosanoids. AIM: To evaluate the role of CTMC and MMC for release of TNF-alpha and eicosanoids after allergenic challenge in distinct segments of rat trachea. MATERIALS AND METHODS: Proximal trachea (PT) and distal trachea (DT) from ovalbumin (OVA)-sensitized rats, treated or not with compound 48/80 (48/80) or dexamethasone, were incubated in culture medium. After OVA challenge, aliquots were collected to study release of TNF-alpha and eicosanoids. RESULTS: Release of TNF-alpha by PT upon OVA challenge peaked at 90 min and decayed at 6 and 24 h. Release from DT peaked at 30-90 min and decayed 6 and 24 h later. When CTMC were depleted with 48/80, OVA challenge exacerbated the TNF-alpha release by PT at all time intervals, while DT exacerbated TNF-alpha levels 6 and 24 h later only. Dexamethasone reduced TNF-alpha production after 90 min of OVA challenge in PT and at 3 and 6h in DT. OVA challenge increased prostaglandin D2) in DT and leukotriene B4 in both segments but did not modify prostaglandin E2 and leukotriene C4 release. CONCLUSION: OVA challenge induces TNF-alpha release from MMC, which is negatively regulated by CTMC. The profile of TNF-alpha and eicosanoids depends on the time after OVA challenge and of the tracheal segment considered.

Full Text

The Full Text of this article is available as a PDF (286.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam R., Dejarnatt A., Stafford S., Forsythe P. A., Kumar D., Grant J. A. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Results of a double-blind, placebo-controlled randomized study. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1066–1070. doi: 10.1164/ajrccm/148.4_Pt_1.1066. [DOI] [PubMed] [Google Scholar]
  2. Almawi W. Y., Beyhum H. N., Rahme A. A., Rieder M. J. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996 Nov;60(5):563–572. doi: 10.1002/jlb.60.5.563. [DOI] [PubMed] [Google Scholar]
  3. Amrani Y., Aubier M., Bronner C. Interactions entre le tumor necrosis factor-alpha et les cellules musculaires lisses des voies aériennes: implications dans la physiopathologie de l'asthme. Rev Mal Respir. 1996 Dec;13(6):539–546. [PubMed] [Google Scholar]
  4. Amrani Y., Chen H., Panettieri R. A., Jr Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? Respir Res. 2000 Jul 3;1(1):49–53. doi: 10.1186/rr12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anticevich S. Z., Hughes J. M., Black J. L., Armour C. L. Induction of human airway hyperresponsiveness by tumour necrosis factor-alpha. Eur J Pharmacol. 1995 Sep 15;284(1-2):221–225. doi: 10.1016/0014-2999(95)00463-u. [DOI] [PubMed] [Google Scholar]
  6. Bernstein J. A., Lawrence I. D. The mast cell: a comprehensive, updated review. Allergy Proc. 1990 Sep-Oct;11(5):209–223. doi: 10.2500/108854190778879882. [DOI] [PubMed] [Google Scholar]
  7. Bradding P., Mediwake R., Feather I. H., Madden J., Church M. K., Holgate S. T., Howarth P. H. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy. 1995 May;25(5):406–415. doi: 10.1111/j.1365-2222.1995.tb01071.x. [DOI] [PubMed] [Google Scholar]
  8. Bradding P., Roberts J. A., Britten K. M., Montefort S., Djukanovic R., Mueller R., Heusser C. H., Howarth P. H., Holgate S. T. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994 May;10(5):471–480. doi: 10.1165/ajrcmb.10.5.8179909. [DOI] [PubMed] [Google Scholar]
  9. Broide D. H., Lotz M., Cuomo A. J., Coburn D. A., Federman E. C., Wasserman S. I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992 May;89(5):958–967. doi: 10.1016/0091-6749(92)90218-q. [DOI] [PubMed] [Google Scholar]
  10. Damazo A. S., Tavares de Lima W., Perretti M., Oliani S. M. Pharmacological modulation of allergic inflammation in the rat airways and association with mast cell heterogeneity. Eur J Pharmacol. 2001 Aug 24;426(1-2):123–130. doi: 10.1016/s0014-2999(01)01093-7. [DOI] [PubMed] [Google Scholar]
  11. Drazen Jeffrey M. Anti-leukotrienes as novel anti-inflammatory treatments in asthma. Adv Exp Med Biol. 2002;507:217–221. doi: 10.1007/978-1-4615-0193-0_33. [DOI] [PubMed] [Google Scholar]
  12. Enerbäck L. Mucosal mast cells in the rat and in man. Int Arch Allergy Appl Immunol. 1987;82(3-4):249–255. doi: 10.1159/000234199. [DOI] [PubMed] [Google Scholar]
  13. Fedan J. S., Frazer D. G. Influence of epithelium on the reactivity of guinea pig isolated, perfused trachea to bronchoactive drugs. J Pharmacol Exp Ther. 1992 Aug;262(2):741–750. [PubMed] [Google Scholar]
  14. Flick D. A., Gifford G. E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods. 1984 Mar 30;68(1-2):167–175. doi: 10.1016/0022-1759(84)90147-9. [DOI] [PubMed] [Google Scholar]
  15. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  16. Ford-Hutchinson A. W. Leukotriene B4 in inflammation. Crit Rev Immunol. 1990;10(1):1–12. [PubMed] [Google Scholar]
  17. Frossard N., Rhoden K. J., Barnes P. J. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther. 1989 Jan;248(1):292–298. [PubMed] [Google Scholar]
  18. Galli S. J. The Paul Kallos Memorial Lecture. The mast cell: a versatile effector cell for a challenging world. Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):14–22. doi: 10.1159/000237497. [DOI] [PubMed] [Google Scholar]
  19. Gibbs L., Carollo M. G., Damazo A. S., Oliani S. M., Perretti M. Time-dependent expression of annexin 1 in a model of chronic granulomatous inflammation. Inflamm Res. 2002 Jun;51(6):300–306. doi: 10.1007/pl00000308. [DOI] [PubMed] [Google Scholar]
  20. Henderson W. R., Jr Role of leukotrienes in asthma. Ann Allergy. 1994 Mar;72(3):272–278. [PubMed] [Google Scholar]
  21. Kips J. C., Tavernier J. H., Joos G. F., Peleman R. A., Pauwels R. A. The potential role of tumour necrosis factor alpha in asthma. Clin Exp Allergy. 1993 Apr;23(4):247–250. doi: 10.1111/j.1365-2222.1993.tb00317.x. [DOI] [PubMed] [Google Scholar]
  22. Laan M., Prause O., Miyamoto M., Sjöstrand M., Hytönen A. M., Kaneko T., Lötvall J., Lindén A. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J. 2003 Mar;21(3):387–393. doi: 10.1183/09031936.03.00303503. [DOI] [PubMed] [Google Scholar]
  23. Lazaar A. L., Amrani Y., Hsu J., Panettieri R. A., Jr, Fanslow W. C., Albelda S. M., Puré E. CD40-mediated signal transduction in human airway smooth muscle. J Immunol. 1998 Sep 15;161(6):3120–3127. [PubMed] [Google Scholar]
  24. Lazarus S. C. Inflammation, inflammatory mediators, and mediator antagonists in asthma. J Clin Pharmacol. 1998 Jul;38(7):577–582. doi: 10.1002/j.1552-4604.1998.tb04463.x. [DOI] [PubMed] [Google Scholar]
  25. Lipworth B. J. Fortnightly review: modern drug treatment of chronic asthma. BMJ. 1999 Feb 6;318(7180):380–384. doi: 10.1136/bmj.318.7180.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lulich K. M., Papadimitriou J. M., Paterson J. W. The isolated lung strip and single open tracheal ring: a convenient combination for characterizing Schultz Dale anaphylactic contractions in the peripheral and central airways of the guinea-pig. Clin Exp Pharmacol Physiol. 1979 Nov-Dec;6(6):625–629. doi: 10.1111/j.1440-1681.1979.tb00046.x. [DOI] [PubMed] [Google Scholar]
  27. Marone G., Spadaro G., De Marino V., Aliperta M., Triggiani M. Immunopharmacology of human mast cells and basophils. Int J Clin Lab Res. 1998;28(1):12–22. doi: 10.1007/s005990050012. [DOI] [PubMed] [Google Scholar]
  28. Matsuoka T., Hirata M., Tanaka H., Takahashi Y., Murata T., Kabashima K., Sugimoto Y., Kobayashi T., Ushikubi F., Aze Y. Prostaglandin D2 as a mediator of allergic asthma. Science. 2000 Mar 17;287(5460):2013–2017. doi: 10.1126/science.287.5460.2013. [DOI] [PubMed] [Google Scholar]
  29. McNeil H. P., Gotis-Graham I. Human mast cell subsets--distinct functions in inflammation? Inflamm Res. 2000 Jan;49(1):3–7. doi: 10.1007/PL00012386. [DOI] [PubMed] [Google Scholar]
  30. Metcalfe D. D., Baram D., Mekori Y. A. Mast cells. Physiol Rev. 1997 Oct;77(4):1033–1079. doi: 10.1152/physrev.1997.77.4.1033. [DOI] [PubMed] [Google Scholar]
  31. Okuda M. Functional heterogeneity of airway mast cells. Allergy. 1999;54 (Suppl 57):50–62. doi: 10.1111/j.1398-9995.1999.tb04406.x. [DOI] [PubMed] [Google Scholar]
  32. Olejnik A. K., Brzezińska-Błaszczyk E. Tumor necrosis factor alpha (TNF-alpha) modulates rat mast cell reactivity. Immunol Lett. 1998 Dec;64(2-3):167–171. doi: 10.1016/s0165-2478(98)00106-0. [DOI] [PubMed] [Google Scholar]
  33. Olejnik A. K., Brzezińska-Błaszczyk E. Tumor necrosis factor alpha (TNF-alpha) modulates rat mast cell reactivity. Immunol Lett. 1998 Dec;64(2-3):167–171. doi: 10.1016/s0165-2478(98)00106-0. [DOI] [PubMed] [Google Scholar]
  34. Oliani S. M., Christian H. C., Manston J., Flower R. J., Perretti M. An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest. 2000 Sep;80(9):1429–1438. doi: 10.1038/labinvest.3780150. [DOI] [PubMed] [Google Scholar]
  35. Pavord I. D., Tattersfield A. E. Bronchoprotective role for endogenous prostaglandin E2. Lancet. 1995 Feb 18;345(8947):436–438. doi: 10.1016/s0140-6736(95)90409-3. [DOI] [PubMed] [Google Scholar]
  36. Pennings H. J., Kramer K., Bast A., Buurman W. A., Wouters E. F. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. Eur Respir J. 1998 Jul;12(1):45–49. doi: 10.1183/09031936.98.12010045. [DOI] [PubMed] [Google Scholar]
  37. Phan S. H., McGarry B. M., Loeffler K. M., Kunkel S. L. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J Leukoc Biol. 1987 Aug;42(2):106–113. doi: 10.1002/jlb.42.2.106. [DOI] [PubMed] [Google Scholar]
  38. Pradelles P., Grassi J., Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985 Jun;57(7):1170–1173. doi: 10.1021/ac00284a003. [DOI] [PubMed] [Google Scholar]
  39. Proust B., Nahori M. A., Ruffie C., Lefort J., Vargaftig B. B. Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic BALB/c and IL-4Ralpha knockout mice. Clin Exp Allergy. 2003 Jan;33(1):119–131. doi: 10.1046/j.1365-2222.2003.01560.x. [DOI] [PubMed] [Google Scholar]
  40. Prussin Calman, Metcalfe Dean D. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S486–S494. doi: 10.1067/mai.2003.120. [DOI] [PubMed] [Google Scholar]
  41. RILEY J. F., WEST G. B. Tissue mast cells: studies with a histamine-liberator of low toxicity (compound 48/80). J Pathol Bacteriol. 1955 Jan-Apr;69(1-2):269–282. doi: 10.1002/path.1700690135. [DOI] [PubMed] [Google Scholar]
  42. Renzetti L. M., Paciorek P. M., Tannu S. A., Rinaldi N. C., Tocker J. E., Wasserman M. A., Gater P. R. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther. 1996 Aug;278(2):847–853. [PubMed] [Google Scholar]
  43. Schmidt-Choudhury A., Furuta G. T., Lavigne J. A., Galli S. J., Wershil B. K. The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol. 1996 Jul 10;171(1):140–146. doi: 10.1006/cimm.1996.0184. [DOI] [PubMed] [Google Scholar]
  44. Schmidt-Choudhury A., Furuta G. T., Lavigne J. A., Galli S. J., Wershil B. K. The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol. 1996 Jul 10;171(1):140–146. doi: 10.1006/cimm.1996.0184. [DOI] [PubMed] [Google Scholar]
  45. Sheffer A. L. The National Asthma Education Program attacks asthma. J Allergy Clin Immunol. 1991 Feb;87(2):468–469. doi: 10.1016/0091-6749(91)90002-6. [DOI] [PubMed] [Google Scholar]
  46. Snyder D. S., Beller D. I., Unanue E. R. Prostaglandins modulate macrophage Ia expression. Nature. 1982 Sep 9;299(5879):163–165. doi: 10.1038/299163a0. [DOI] [PubMed] [Google Scholar]
  47. Souhrada M., Klein J. J., Berend N., Souhrada J. F. Topographical differences in the physiological response of canine airway smooth muscle. Respir Physiol. 1983 May;52(2):245–258. doi: 10.1016/0034-5687(83)90009-9. [DOI] [PubMed] [Google Scholar]
  48. Straus A. H., Travassos L. R., Takahashi H. K. A monoclonal antibody (ST-1) directed to the native heparin chain. Anal Biochem. 1992 Feb 14;201(1):1–8. doi: 10.1016/0003-2697(92)90167-6. [DOI] [PubMed] [Google Scholar]
  49. Tam E. K., Calonico L. D., Nadel J. A., McDonald D. M. Globule leukocytes and mast cells in the rat trachea: their number, distribution, and response to compound 48/80 and dexamethasone. Anat Embryol (Berl) 1988;178(2):107–118. doi: 10.1007/BF02463644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vargaftig B. B., Lefort J. Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig. Prostaglandins. 1979 Oct;18(4):519–528. doi: 10.1016/0090-6980(79)90020-0. [DOI] [PubMed] [Google Scholar]
  51. Walmrath D., Schneider U., Kreusler B., Grimminger F., Ennis M., Seeger W. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. J Appl Physiol (1985) 1991 Dec;71(6):2499–2506. doi: 10.1152/jappl.1991.71.6.2499. [DOI] [PubMed] [Google Scholar]
  52. Walsh L. J., Trinchieri G., Waldorf H. A., Whitaker D., Murphy G. F. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4220–4224. doi: 10.1073/pnas.88.10.4220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wang C. G., Du T., Xu L. J., Martin J. G. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis. 1993 Aug;148(2):413–417. doi: 10.1164/ajrccm/148.2.413. [DOI] [PubMed] [Google Scholar]
  54. Watson M. L., Smith D., Bourne A. D., Thompson R. C., Westwick J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol. 1993 Apr;8(4):365–369. doi: 10.1165/ajrcmb/8.4.365. [DOI] [PubMed] [Google Scholar]
  55. Williams C. M., Galli S. J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol. 2000 May;105(5):847–859. doi: 10.1067/mai.2000.106485. [DOI] [PubMed] [Google Scholar]
  56. Ying S., Robinson D. S., Varney V., Meng Q., Tsicopoulos A., Moqbel R., Durham S. R., Kay A. B., Hamid Q. TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy. 1991 Nov;21(6):745–750. doi: 10.1111/j.1365-2222.1991.tb03205.x. [DOI] [PubMed] [Google Scholar]
  57. Zimmermann I., Walkenhorst M., Ulmer W. T. The location of sensoric bronchoconstricting receptors in the upper airways. Respiration. 1979;38(1):1–11. doi: 10.1159/000194052. [DOI] [PubMed] [Google Scholar]
  58. de Lima W. T., da Silva Z. L. Contractile responses of proximal and distal trachea segments isolated from rats subjected to immunological stimulation: role of connective tissue mast cells. Gen Pharmacol. 1998 May;30(5):689–695. doi: 10.1016/s0306-3623(97)00377-7. [DOI] [PubMed] [Google Scholar]
  59. de Oliveira Elias M., Tavares de Lima W., Vannuchi Y. B., Marcourakis T., da Silva Z. L., Trezena A. G., Scavone C. Nitric oxide modulates Na+, K+-ATPase activity through cyclic GMP pathway in proximal rat trachea. Eur J Pharmacol. 1999 Feb 19;367(2-3):307–314. doi: 10.1016/s0014-2999(98)00928-5. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES